(Q36936796)

17 August 2017

1 reference

title

Multimodality imaging of the HER-kinase axis in cancer (English)

1 reference

17 August 2017

3

Xiaoyuan Chen

1 reference

17 August 2017

2

Gang Niu

1 reference

17 August 2017

1

Weibo Cai

1 reference

17 August 2017

11 September 2007

1 reference

17 August 2017

23

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

17 August 2017

35

1 reference

17 August 2017

1

1 reference

17 August 2017

186-208

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-007-0560-9

17 August 2017

0 references

cites work

The HER receptor family: a rich target for therapeutic development

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0560-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0560-9

Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0560-9

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0560-9

HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0560-9

Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0560-9

Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0560-9

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0560-9

A combined PET/CT scanner: the path to true image fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0560-9

Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor

21 January 2018

1 reference

12 December 2020

Functional imaging in CT.

1 reference

12 December 2020

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging

1 reference

12 December 2020

Gold nanoshell bioconjugates for molecular imaging in living cells

1 reference

12 December 2020

Increased bioavailability of intravenous versus oral CI-1033, a pan erbB tyrosine kinase inhibitor: results of a phase I pharmacokinetic study

1 reference

12 December 2020

Cell signaling by receptor tyrosine kinases

1 reference

12 December 2020

Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.

1 reference

12 December 2020

Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects

1 reference

12 December 2020

Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors

1 reference

12 December 2020

Panitumumab the first fully human monoclonal antibody: from the bench to the clinic

1 reference

12 December 2020

Forming Biocompatible and Nonaggregated Nanocrystals in Water Using Amphiphilic Polymers

1 reference

12 December 2020

Time-domain optical mammography SoftScan: initial results

1 reference

12 December 2020

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

1 reference

12 December 2020

HER-2-targeted therapy: lessons learned and future directions.

1 reference

12 December 2020

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck

1 reference

12 December 2020

New anatomical and functional imaging methods

1 reference

12 December 2020

Quantum dot bioconjugates for ultrasensitive nonisotopic detection.

1 reference

12 December 2020

Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.

1 reference

12 December 2020

17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts

1 reference

12 December 2020

Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference

1 reference

12 December 2020

Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies

1 reference

12 December 2020

Clinical applications: MRI, SPECT, and PET.

1 reference

12 December 2020

1 reference

12 December 2020

Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET

1 reference

12 December 2020

Labeling of polypeptides with technetium-99m using a dextran spacer

1 reference

12 December 2020

Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer

1 reference

12 December 2020

Comparison of benzoate- and dodecaborate-based linkers for attachment of radioiodine to HER2-targeting Affibody ligand.

1 reference

12 December 2020

Newer methods of labeling diagnostic agents with Tc-99m

1 reference

12 December 2020

Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer

1 reference

12 December 2020

Lymphoscintigraphy using epidermal growth factor as tumour-seeking agent in uterine cervical cancer

1 reference

12 December 2020

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

1 reference

12 December 2020

Immunotargeted nanoshells for integrated cancer imaging and therapy

1 reference

12 December 2020

Optical imaging of cervical pre-cancers with structured illumination: an integrated approach

1 reference

12 December 2020

Semiconductor quantum dots for in vivo imaging

1 reference

12 December 2020

Detection and analysis of tumor fluorescence using a two-photon optical fiber probe

1 reference

12 December 2020

Radioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor.

1 reference

12 December 2020

The tyrosine kinase inhibitor PD153035: implication of labeling position on radiometabolites formed in vitro

1 reference

12 December 2020

Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer

1 reference

12 December 2020

Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells

1 reference

12 December 2020

Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.

1 reference

12 December 2020

Magnetic resonance molecular imaging of the HER-2/neu receptor

1 reference

12 December 2020

Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.

1 reference

12 December 2020

Simultaneous PET and MR imaging

1 reference

12 December 2020

The promise of immuno-PET in radioimmunotherapy

1 reference

12 December 2020

Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles

1 reference

12 December 2020

Biodistribution of 211At labeled HER-2 binding affibody molecules in mice

1 reference

12 December 2020

Are quantum dots ready for in vivo imaging in human subjects?

1 reference

12 December 2020

Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical.

1 reference

12 December 2020

Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor

1 reference

12 December 2020

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

1 reference

12 December 2020

Radionuclide imaging in drug development.

1 reference

12 December 2020

Radiobromination of monoclonal antibody using potassium [76Br] (4 isothiocyanatobenzyl-ammonio)-bromo-decahydro-closo-dodecaborate (Bromo-DABI).

1 reference

12 December 2020

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

1 reference

12 December 2020

In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice

1 reference

12 December 2020

99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy.

1 reference

12 December 2020

Radiolocalization of squamous lung carcinoma with 131I-labeled epidermal growth factor

1 reference

12 December 2020

Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers

1 reference

12 December 2020

Lymphoscintigraphy with 13I-labelled epidermal growth factor

1 reference

12 December 2020

Dual-isotope myocardial perfusion SPECT with rest thallium-201 and stress Tc-99m sestamibi

1 reference

12 December 2020

In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.

1 reference

12 December 2020

Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice

1 reference

12 December 2020

Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers

1 reference

12 December 2020

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors.

1 reference

12 December 2020

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

1 reference

12 December 2020

Quantum dots for live cells, in vivo imaging, and diagnostics

1 reference

12 December 2020

A new bifunctional chelating agent conjugated with monoclonal antibody and labelled with technetium-99m for targeted scintigraphy: 6-(4-isothiocyanatobenzyl)-5,7-dioxo-1,11-(carboxymethyl)-1,4,8,11-tetraazacyclotridecane

1 reference

12 December 2020

Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy

1 reference

12 December 2020

Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner.

1 reference

12 December 2020

18F labeling for immuno-PET: where speed and contrast meet.

1 reference

12 December 2020

Preliminary study on radioimmunodiagnosis of experimental tumor models using technetium-99m-labeled anti-C-erbB-2 monoclonal antibody

1 reference

12 December 2020

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer

1 reference

12 December 2020

Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids

1 reference

12 December 2020

Lighting up cells: labelling proteins with fluorophores

1 reference

12 December 2020

Transformational and altered signal transduction by a naturally occurring mutant EGF receptor

1 reference

12 December 2020

Bifunctional chelating agents for radiometal-labeled monoclonal antibodies

1 reference

12 December 2020

Optical bioimaging: from living tissue to a single molecule: single-molecule visualization of cell signaling processes of epidermal growth factor receptor.

1 reference

12 December 2020

A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression

1 reference

12 December 2020

Optoacoustic determination of optical attenuation depth using interferometric detection

1 reference

12 December 2020

Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression

1 reference

12 December 2020

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

1 reference

12 December 2020

Numerical selection of optimal tumor imaging agents with application to engineered antibodies

1 reference

12 December 2020

Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy.

1 reference

12 December 2020

Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients

1 reference

12 December 2020

Figures of merit (FOMs) for imaging and therapy using monoclonal antibodies

1 reference

12 December 2020

1 reference

12 December 2020

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.

1 reference

12 December 2020

Semiconductor nanocrystals as fluorescent biological labels

1 reference

12 December 2020

The achilles heel of ErbB-2/HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention.

1 reference

12 December 2020

A new monoclonal antibody for detection of EGF-receptors in western blots and paraffin-embedded tissue sections

1 reference

12 December 2020

Purification method directly influences effectiveness of an epidermal growth factor-coupled targeting agent for noninvasive tumor detection in mice

1 reference

12 December 2020

Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity

1 reference

12 December 2020

Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors

1 reference

12 December 2020

PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.

1 reference

12 December 2020

MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents

1 reference

12 December 2020

Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography

1 reference

12 December 2020

Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats.

1 reference

12 December 2020

Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2:342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma.

1 reference

12 December 2020

Evolution of Tc-99m in diagnostic radiopharmaceuticals

1 reference

12 December 2020

c-erbB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodies

1 reference

12 December 2020

A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer

1 reference

12 December 2020

Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors

1 reference

12 December 2020

Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial

1 reference

12 December 2020

Positron emission tomography: radioisotope and radiopharmaceutical production.

1 reference

12 December 2020

Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm

1 reference

12 December 2020

111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.

1 reference

12 December 2020

Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent

1 reference

12 December 2020

Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer

1 reference

12 December 2020

Quantum dot bioconjugates for imaging, labelling and sensing

1 reference

12 December 2020

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.

1 reference

12 December 2020

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib

1 reference

12 December 2020

Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner

1 reference

12 December 2020

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

12 December 2020

Targeting the HER-kinase axis in cancer

1 reference

12 December 2020

Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody

1 reference

12 December 2020

Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors

1 reference

12 December 2020

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

1 reference

12 December 2020

Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF

1 reference

12 December 2020

Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots

1 reference

12 December 2020

Therapeutic potential of RNA interference

1 reference

12 December 2020

Multimodality tumor imaging targeting integrin alphavbeta3.

1 reference

12 December 2020

The development and clinical use of trastuzumab (Herceptin).

1 reference

12 December 2020

The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy

1 reference

12 December 2020

Role of HER2/neu in tumor progression and therapy

1 reference

12 December 2020

[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.

1 reference

12 December 2020

Arming antibodies: prospects and challenges for immunoconjugates

1 reference

12 December 2020

Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).

1 reference

12 December 2020

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts

1 reference

12 December 2020

[99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation.

1 reference

12 December 2020

Selection and characterization of HER2/neu-binding affibody ligands

1 reference

12 December 2020

Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.

1 reference

12 December 2020

Expression Cloning of Human EGF Receptor Complementary DNA: Gene Amplification and Three Related Messenger RNA Products in A431 Cells

1 reference

12 December 2020

Indium-111-labeled anti-EGFr-425 scintigraphy in the detection of malignant gliomas.

1 reference

12 December 2020

Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy

1 reference

12 December 2020

Targeting HER1/EGFR: a molecular approach to cancer therapy

1 reference

12 December 2020

Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer

1 reference

12 December 2020

Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization.

1 reference

12 December 2020

CI-1033, a pan-erbB tyrosine kinase inhibitor

1 reference

12 December 2020

ErbB-4: mechanism of action and biology

1 reference

12 December 2020

Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging

1 reference

12 December 2020

In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR) signaling in cancer

1 reference

12 December 2020

Targeting Hsp90 for the treatment of cancer.

1 reference

12 December 2020

A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumors

1 reference

12 December 2020

A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.

1 reference

12 December 2020

Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.

1 reference

12 December 2020

Noninvasive imaging of transcriptionally restricted transgene expression following intratumoral injection of an adenovirus in which the COX-2 promoter drives a reporter gene

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells.

1 reference

12 December 2020

How molecular imaging is speeding up antiangiogenic drug development

1 reference

12 December 2020

Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer

1 reference

12 December 2020

A tabulated summary of the FDG PET literature.

1 reference

12 December 2020

The epidermal growth factor (EGF).

1 reference

12 December 2020

Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors

1 reference

12 December 2020

The complexity of targeting EGFR signalling in cancer: from expression to turnover

1 reference

12 December 2020

Role of HER receptors family in development and differentiation.

1 reference

12 December 2020

Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging.

1 reference

12 December 2020

Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors

1 reference

12 December 2020

A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies

1 reference

12 December 2020

A review of small animal imaging planar and pinhole spect Gamma camera imaging

1 reference

12 December 2020

Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.

1 reference

12 December 2020

Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.

1 reference

12 December 2020

Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer

1 reference

12 December 2020

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas

1 reference

12 December 2020

Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice

1 reference

12 December 2020

Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC.

1 reference

12 December 2020

Scintigraphic detection of overexpressed c-erbB-2 protooncogene products by a class-switched murine anti-c-erbB-2 protein monoclonal antibody

1 reference

12 December 2020

Molecular optical imaging of therapeutic targets of cancer

1 reference

12 December 2020

Advances in in vivo bioluminescence imaging of gene expression

1 reference

12 December 2020

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

1 reference

12 December 2020

Molecular imaging by MRI.

1 reference

12 December 2020

Molecular imaging in living subjects: seeing fundamental biological processes in a new light

1 reference

12 December 2020

Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments

1 reference

12 December 2020

In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules

1 reference

12 December 2020

Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride

1 reference

12 December 2020

Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents

1 reference

12 December 2020

Antitumor Activity of Combined Blockade of Epidermal Growth Factor Receptor and Protein Kinase A

1 reference

12 December 2020

Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody

1 reference

12 December 2020

Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments.

1 reference

12 December 2020

A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin

1 reference

12 December 2020

Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.

1 reference

12 December 2020

Insights from transgenic mouse models of ERBB2-induced breast cancer

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer

1 reference

12 December 2020

Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging.

1 reference

12 December 2020

High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors

1 reference

12 December 2020

Reduction in nonfluorescence state of quantum dots on an immunofluorescence staining

1 reference

12 December 2020

PET of vascular endothelial growth factor receptor expression.

1 reference

12 December 2020

Tomographic fluorescence mapping of tumor targets

1 reference

12 December 2020

The c-erbB3/HER3 receptor in human cancer.

1 reference

12 December 2020

Emerging concepts in molecular MRI.

1 reference

12 December 2020

Overexpression of HER2/neu in solid tumours: an immunohistochemical survey

1 reference

12 December 2020

The fluorescent toolbox for assessing protein location and function

1 reference

12 December 2020

Engineered antibody fragments and the rise of single domains

1 reference

12 December 2020

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor

1 reference

12 December 2020

Instrumentation for molecular imaging in preclinical research: Micro-PET and Micro-SPECT.

1 reference

12 December 2020

Lessons from the drug discovery of lapatinib, a dual ErbB1/2 tyrosine kinase inhibitor

1 reference

12 December 2020

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.

1 reference

12 December 2020

Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET.

1 reference

12 December 2020

Fluorescent nanocrystals for use in early cervical cancer detection

1 reference

12 December 2020

A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer

1 reference

12 December 2020

Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system

1 reference

12 December 2020

Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody

1 reference

12 December 2020

In vivo study of a technetium labelled anti-EGFr MoAB

1 reference

12 December 2020

A far-red fluorescent contrast agent to image epidermal growth factor receptor expression

1 reference

12 December 2020

Gefitinib--a novel targeted approach to treating cancer

1 reference

12 December 2020

In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.

1 reference

12 December 2020

Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence.

1 reference

12 December 2020

Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase

1 reference

12 December 2020

Current status of cetuximab for the treatment of patients with solid tumors.

1 reference

12 December 2020

Perspectives on anti-HER monoclonal antibodies

1 reference

12 December 2020

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

1 reference

12 December 2020

Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.

1 reference

12 December 2020

Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses

1 reference

12 December 2020

Clinical applicability of functional MRI.

1 reference

12 December 2020

Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer.

1 reference

12 December 2020

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

1 reference

12 December 2020

Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion.

1 reference

12 December 2020

MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles

1 reference

12 December 2020

1 reference

12 December 2020

Lapatinib: a novel EGFR/HER2 tyrosine kinase inhibitor for cancer.

1 reference

12 December 2020

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

1 reference

12 December 2020

In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants.

1 reference

12 December 2020

Radionuclide imaging in the post-genomic era.

1 reference

12 December 2020

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

1 reference

12 December 2020

Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody

1 reference

12 December 2020

Amplified delivery of indium-111 to EGFR-positive human breast cancer cells

1 reference

12 December 2020

Activated neu induces rapid tumor progression.

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer

1 reference

12 December 2020

A combined PET/CT scanner for clinical oncology.

1 reference

12 December 2020

1 reference

12 December 2020

Antibody engineering for the development of therapeutic antibodies

1 reference

12 December 2020

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics

1 reference

12 December 2020

Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody

1 reference

12 December 2020

Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.

1 reference

12 December 2020

Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging

1 reference

12 December 2020

1 reference

12 December 2020

Revealing the world of RNA interference

1 reference

12 December 2020

18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.

1 reference

12 December 2020

10.1007/S00259-007-0560-9

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17846765